Abeona Therapeutics Inc (ABEO) – Strategy, SWOT and Corporate Finance Report
- Pages: 46
- Published: June 2023
- Report Code: MLPH55346FSA
Abeona Therapeutics Inc (ABEO) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals Inc, is a biopharmaceutical company that develops and delivers gene therapy and plasma-based products for severe life-threatening rare diseases. The company’s lead programs include EB-101, ABO-101 and ABO-102 adeno-associated virus. Abeona develops EB-101 for recessive dystrophic epidermolysis bullosa (RDEB), EB-201 for epidermolysis bullosa (EB), ABO-202 (AAV-CLN1) gene therapy for the treatment of infantile Batten disease (INCL), ABO-201 (AAV-CLN3) gene therapy for Juvenile Batten disease (JNCL) and more. The company has partnerships for the commercialization of its products in the US, European Union, Switzerland, Norway, Iceland, Lichtenstein, Australia, New Zealand, China and South Korea. Abeona is headquartered in New York City, the US.
Scope
• Detailed information on Abeona Therapeutics Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Abeona Therapeutics Inc in the form of a SWOT analysis
• An in-depth view of the business model of Abeona Therapeutics Inc including a breakdown and examination of key business segments
• News about Abeona Therapeutics Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Abeona Therapeutics Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Abeona Therapeutics Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Abeona Therapeutics Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Synedgen Inc
Krystal Biotech Inc
Jazz Pharmaceuticals Plc
Grifols SA
Galera Therapeutics Inc
G1 Therapeutics Inc
Camurus AB
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.